Abstract
The Pharmaceutical Journal of Sri Lanka is the official scientific publication of the Pharmaceutical Society of Sri Lanka. Authors are invited to submit articles throughout the year, and if accepted after a blinded peer review process, will be published online in one of the two issues published each year. The journal including both issues will be printed only once a year. The Pharmaceutical Journal of Sri Lanka aims at providing an avenue for publications by pharmacy undergraduates, university academics, pharmacists and pharmaceutical scientist of Sri Lanka and the South Asian region. The journal accepts original research work either as a full research paper or as a short communication, review, brief report, special communication, commentary, case study and other categories of articles related to pharmaceutical sciences. Articles are accepted on the understanding that they have not been published elsewhere.
Highlights
Antimicrobial Resistance (AMR) was antimicrobial medicines consumption introduced by the World Health Organization (AMC) which is the main driver of AMR are (WHO) in 2015
To implement the objectives of GAP, in 2016 the WHO developed a standardized global methodology for the measurement of Antimicrobial Medicines Consumption (AMC), based on the Anatomical Therapeutic Chemical (ATC)/ Defined Daily Dose (DDD)-methodology of WHO, and the methodologies established by European Surveillance of Antimicrobial Consumption (ESAC)-Net and the WHO Regional Office for Europe so that data can be compared and exchanged globally
Trends and drivers of consumption of J01 Between 1994 and 2018 AMC expressed in Defined Daily Doses (DDDs), increased by 143% (44.4 – 108.2 million DDDs)
Summary
Antimicrobial Resistance (AMR) was antimicrobial medicines consumption introduced by the World Health Organization (AMC) which is the main driver of AMR are (WHO) in 2015. This license permits use, distribution and reproduction in any medium, provided the original work is properly cited. State of the WHO, the Ministry of Health, Sri Lanka launched its strategic plan to curb AMR in 2017 using the “One Health” approach (2) which includes both humans and animals. South-East Asia region (SEAR) was selected for the pilot study, due to the lack of data, SEAR was excluded in the WHO report on surveillance of antibiotic consumption from 2016 – 2018.(3).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
